Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of Single Ascending Doses of CSL889 in Adult Patients With Stable Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04285827
Recruitment Status : Not yet recruiting
First Posted : February 26, 2020
Last Update Posted : April 23, 2021
Sponsor:
Information provided by (Responsible Party):
CSL Behring

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2022